Publications by authors named "Sema Turker"

Claim this Profile
E
Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study.
İlknur Deliktaş Onur, Mutlu Doğan, Mehmet Akif Öztürk, Taha Koray Sahin, Murat Kiracı

Curr Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study.
Safa Can Efil, Burak Bilgin, Irem Bilgetekin, Kaan Helvaci, Teoman Sakalar, Sema Turker

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study.
Özgecan Dülgar, Sema Türker, Gül Başaran, Murat Araz, Ahmet Taner Sümbül

J Chemother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.
Osman Köstek, Ahmet Demirel, Muhammet Bekir Hacıoğlu, Didem Tastekin, Senem Karabulut, Sema Turker

J Chemother· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study.
Okan Avcı, Yakup İriağaç, Eyyüp Çavdar, Kubilay Karaboyun, Murat Araz

J Geriatr Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of HER2-Low Status on Pathological Complete Response and Survival in Triple-Negative Breast Cancer: A Systemic Review and Meta-Analysis.
Yakup Ergun, Baran Akagunduz, Cengiz Karacin, Sema Turker, Gokhan Ucar

Clin Breast Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
Cengiz Karacin, Berna Oksuzoglu, Ayşe Demirci, Merve Keskinkılıç, Naziyet Köse Baytemür

BMC Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
Cengiz Karacin, Berna Oksuzoglu, Ayşe Demirci, Merve Keskinkılıç, Naziyet Köse Baytemür

BMC Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.
Selin Aktürk Esen, Yakup Ergun, Cihan Erol, Rukiye Arikan, Muhammed Muhiddin Er

Bosn J Basic Med Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).
Cihan Erol, Abdullah Sakin, Tuğba Başoğlu, Ercan Özden, Devrim Çabuk

Turk J Med Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.
Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray

J Gastrointest Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acrometastasis of Laryngeal Carcinoma to the Finger.
Cengiz Karacin, Sema Turker, Dogan Yazilitas, Tulay Eren, Tugba Taskin Turkmenoglu

J Coll Physicians Surg Pak· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study.
Ahmet Bilici, Mukremin Uysal, Serkan Menekse, Semih Akin, Fatih Yildiz, Sema Turker

Cancer Invest· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of lymph node ratio on overall survival in patients with colorectal cancer.
Goksen İnanğ İmamoğlu, Arzu Oğuz, Sanem Cimen, Tülay Eren, Cengiz Karacin

J Cancer Res Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relation between inflammation-based parameters and survival in metastatic pancreatic cancer.
Sema Turker, Ebru Cilbir, Deniz Can Guven, Cengiz Karacin, Suayib Yalcin

J Cancer Res Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.
Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray

Tumori· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.
Muhammet Bekir Hacioglu, Osman Kostek, Senem Karabulut, Didem Tastekin, Sema Sezgin Goksu, Sema Turker

J BUON· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hematologic inflammatory index is a new prognostic marker in patients resected for gastric cancer.
Hayriye Sahinli, Sema Türker

J Cancer Res Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
Ali Alkan, Arzu Yaşar, Zeynep Gülsüm Güç, Mustafa Gürbüz, Tuğba Başoğlu

Eur J Cancer Care (Engl)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment.
Sema Turker, Ebru Cilbir, Cengiz Karacin, Mustafa Altinbas

J Cancer Res Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Neoplasia in Colonic Wall Thickening Detected via Computerized Tomography.
Cengiz Karacin, Sema Türker, Tulay Eren, Goksen Inanc Imamoglu, Kemalettin Yılmaz

Cureus· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-to-tumor metastasis: Breast cancer metastasis to lung cancer.
Sema Turker, Ebru Çılbır, Kerim Bora Yilmaz, Efe Yetişgin, Gökşen İmamoğlu

Breast J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM proteases involved in inflammation are differentially altered in patients with gastritis or ulcer.
Nuray Erin, Sema Türker, Özlem Elpek, Bülent Yildirim

Exp Ther Med· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential changes in Substance P, VIP as well as neprilysin levels in patients with gastritis or ulcer.
Nuray Erin, Sema Türker, Ozlem Elpek, Bülent Yıldırım

Peptides· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung involvement in patients with primary Sjögren's syndrome: what are the predictors?
Veli Yazisiz, Gokhan Arslan, Irem Hicran Ozbudak, Sema Turker, Funda Erbasan

Rheumatol Int· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis